Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1016/s0140-6736(20)31484-7

Type

Journal

Lancet (London, England)

Publication Date

07/2020

Volume

396

Pages

e6 - e7

Addresses

Department of Clinical Virology, University College London Hospitals, London W1T 4EU, UK; Department of Infection and Immunity, University College London, London, UK; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.

Keywords

Crick COVID-19 Consortium, SAFER Investigators, Humans, Cross Infection, Pneumonia, Viral, Coronavirus Infections, Antibodies, Viral, Risk Assessment, Prospective Studies, Occupational Exposure, Adult, Health Personnel, London, Infectious Disease Transmission, Patient-to-Professional, Pandemics, Seroconversion, Betacoronavirus, COVID-19, SARS-CoV-2